Ishida Ryosuke, Matsumoto Hirokazu, Ichii Sayaka, Kobayashi Motomasa, Arai Masayoshi, Kotoku Naoyuki
Graduate School of Pharmaceutical Sciences, Osaka University.
Chem Pharm Bull (Tokyo). 2019 Mar 1;67(3):210-223. doi: 10.1248/cpb.c18-00587. Epub 2018 Nov 14.
The tumor microenvironment is considered as one of the important targets for anticancer drug discovery. In particular, nutrient deficiency may be observed in tumor microenvironment; biakamides A-D (1-4) isolated from marine sponge Petrosaspongia sp. as growth inhibitors against cancer cells adapted to glucose-deprived conditions have potential as new drugs and tools for elucidating adaptation mechanisms to these conditions. In this paper, we investigated structure-activity relationship (SAR) of biakamide to create easily accessible analog and gain insights about participation of the substructures to growth-inhibitory activity toward development of anticancer drug. This work revealed that 14,15-dinor-biakamide C (5), which is easily accessible, has similar activity to natural biakamide C (3). In addition, detailed SAR study showed the terminal acyl chain is important for interacting with target molecule and amide part including thiazole ring has acceptability to convert structures without losing activity.
肿瘤微环境被认为是抗癌药物研发的重要靶点之一。特别是在肿瘤微环境中可能会观察到营养物质缺乏的情况;从海洋海绵Petrosaspongia sp.中分离出的比亚卡胺A-D(1-4)作为针对适应葡萄糖缺乏条件的癌细胞的生长抑制剂,具有作为新药和阐明这些条件下适应机制的工具的潜力。在本文中,我们研究了比亚卡胺的构效关系(SAR),以创建易于获得的类似物,并深入了解亚结构对癌细胞生长抑制活性的参与情况,从而推动抗癌药物的开发。这项工作表明,易于获得的14,15-二降-比亚卡胺C(5)具有与天然比亚卡胺C(3)相似的活性。此外,详细的构效关系研究表明,末端酰基链对于与靶分子相互作用很重要,包括噻唑环的酰胺部分在不丧失活性的情况下对结构转化具有可接受性。